Implementation sits outside Part D, with Humana handling PA, adjudication, and reimbursement; manufacturers provide a $245 net price for Wegovy, Zepbound, and orforglipron. Eligibility requires PA and ...

CLEVELAND, Ohio — Eligible Americans on Medicare may be able to get a month’s supply of some GLP-1 drugs for $50 from July 1 through the end of the year, the Centers for Medicare & Medicaid Services ...

The Institute of Management Accountants announced the availability of its new AI in Finance Micro-credential as part of a larger rollout of similar credentials for specialized finance and accounting ...

More access to affordable weight-loss medications is coming this summer for adults on Medicare. Starting in July, certain Medicare enrollees can pay $50 a month for specific prescription GLP1 ...

The initiative is part of the administration’s focus on addressing technology and cybersecurity vacancies by placing an emphasis on skill-based hiring. The Department of Defense is launching a Cyber ...

S15 - E19 Reunion Part 1 The reunion kicks off with some of the ladies seeking resolution while others remain doubtful following an emotionally charged season. A red-carpet sighting sparks questions ...

WASHINGTON, April 23 (Reuters) - The Trump administration has approved only one Gold Card visa under a program granting U.S. residency to non-citizens for a $1 million fee, ‌Commerce Secretary Howard ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Customers will be able to compare insurance and cash-pay prices at checkout, with manufacturer coupons automatically applied to those eligible. (iStock / Getty Images Plus) Amazon One Medical has ...

The bridge program operates outside of the Part D plan's usual payment flow, so insurers do not have to opt in and will not carry risk for drugs furnished under the model, CMS said on its website.

Amazon.com AMZN-4.21%decrease; down pointing triangle is launching a program that provides access to GLP-1 treatments through its One Medical primary care arm. The company said Tuesday the new program ...